Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 666 restricted stock units (RSUs) to two newly-hired employees. These RSU awards were granted as of June 30, 2025 (the “Grant Date”) pursuant to the Company's 2022 Inducement Stock Incentive Plan, as amended, […]
Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation, and interconnection solutions, announced today that it will release financial results for the second quarter of 2025 after the market closes on Thursday, July 24, 2025. The company will host a conference call to discuss these results at 5:00 p.m.
Clearwater Properties Celebrates Grand Re-Opening of White Sulphur Springs Office GlobeNewswire July 01, 2025 WHITE SULPHUR SPRINGS, Mont., July 01, 2025 (GLOBE NEWSWIRE) — Clearwater Properties proudly celebrated the grand re-opening of its White Sulphur Springs office on Friday, June 27, 2025. The event, held from 4:00 p.m. to 8:00 p.m., welcomed community members, clients,
ONE Gas, Inc. (NYSE:OGS) announces the retirement of Joseph L. McCormick as senior vice president, general counsel and assistant corporate secretary, effective October 1, 2025. The ONE Gas Board of Directors has elected Regina L. Gregory to succeed McCormick as senior vice president, general counsel and assistant corporate secretary. https://mma.prnewswire.com/media/1424336/ONE_Gas_v1_Logo.jpg McCormick has been an integral
Calamos Investments®* has announced monthly distributions and sources of distributions paid in July 2025 to shareholders of its seven closed-end funds (the Funds) pursuant to the Funds' respective distribution plans. Fund Distribution Payabledate Record date Ex-dividend dateCHI(inception06/26/2002) $0.0950 7/21/25 7/14/25 7/14/25Calamos Convertible Opportunities and Income FundCHY(inception05/28/2003) $0.1000 7/21/25 7/14/25 7/14/25CalamosConvertibleandHighIncome FundCSQ(inception03/26/2004) $0.1025 7/21/25 7/14/25 7/14/25CalamosStrategicTotal
AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, today announced that it will release financial results for its fourth quarter of fiscal year 2025, ended May 31, 2025, after the close of the New York Stock Exchange trading session on Wednesday, July 16, 2025. https://mma.prnewswire.com/media/2305023/AAR_Logo.jpg
Post Holdings, Inc. (NYSE: Post) (“Post”), a consumer packaged goods holding company, announced today it has completed the previously announced acquisition of 8th Avenue Food & Provisions, Inc., effective July 1, 2025. https://mma.prnewswire.com/media/2459527/Post_Holdings_Logo.jpg About Post Holdings, Inc. Post Holdings, Inc., headquartered in St. Louis, Missouri, is a consumer packaged goods holding company with businesses operating
(NASDAQ:CUE), ORR of 50% in treatment-naive patients with HPV+ R/M HNSCC12-month landmark survival of 88% and mOS of 32 months BOSTON, July 01, 2025 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of
(NASDAQ:PECO), CINCINNATI, July 01, 2025 (GLOBE NEWSWIRE) — Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation's largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, will announce its Second Quarter 2025 earnings results on Thursday, July 24, 2025, after the market closes. PECO's earnings release and supplemental
(NasdaqGM:AVBP),(NasdaqGM:AVBP), NEWTOWN SQUARE, Pa., July 01, 2025 (GLOBE NEWSWIRE) — ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it intends to offer and sell, subject to market and other conditions, $75 million of its shares of common stock and, in lieu